SURVANTA (beractant) Survanta For the treatment and prevention
Health Care Professionals Parent Information Prescribing Information
 
Home
Download the 2007 NeoFax Manual.
Click Here

Watch the Survanta Dosing Video
Click Here

Download the National Respiratory Disease Newsletter
Click Here

Health Care ProfessionalsOver 800,000 infants treated since 1991*
Clinical Studies
Additional Studies
Follow-Up Studies
Prenatal Corticosteroids and Postnatal Surfactant
Epidemiologic Research
Surfactant Therapy Overview

Additional Studies

Ramanathan R, Rasmussen M, Gerstmann D, et al: A randomized multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Am J Perinatol 2004; 21:109-120.

Vermont-Oxford Neonatal Network: A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome.
Pediatrics 1996;97:1-6.

Bloom BT, Kattwinkel J, Hall RT, et al: Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome.
Pediatrics 1997;100:31-38.

Horbar JD, Wright LL, Soll RF, et al: A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome.
J Pediatr 1993;123:757-766.

* IMS DDD Lung Surfactant Market Purchases July 1991 through June 2008. On file, Abbott Nutrition Marketing Research.